Japanese Drug Makers Rush To Set Up Sales Units In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Japan's largest drug makers have plans, some to take effect as early as this year, to begin expanding into emerging markets to supplant dwindling sales in the large ones